2021 Virtual Pharmaceutical EHS and Sustainability Roundtable

Below you will find the materials for the 2021 Spring Pharmaceutical EHS and Sustainability Roundtable, held virtually on Wednesday, March 3 from 12:00-2:00 p.m. ET

Agenda

Antitrust Guidelines

Presentations

Priorities and Outlook for Biden-Harris Administration
Presented by John Cruden and Allyn Stern

Roundup of Current Issues: Ethylene Oxide, Plastics, COVID-19 Workplace Requirements, and Prop 65
Facilitated by Merrill Fliederbaum, Retired Assistant General Counsel, Pfizer Inc
Presented by David Friedland (EO), Dacie Meng (Plastics), Jayni Lanham (OSHA), and Aminah Famili (Prop 65)

Feedback

Please email Paul Hagen, [email protected] with feedback on the Roundtable or suggestions for future programs. 

About the Roundtable

Launched in 2007, the Pharmaceutical EHS and Sustainability Roundtable provides an opportunity for in-house counsel and EHS professionals at leading pharmaceutical companies to meet and discuss emerging environmental, supply chain, and sustainability issues pertaining to pharmaceutical products and operations in the United States and key markets worldwide. The Roundtable also affords participants an opportunity to discuss compliance approaches, opportunities to reduce legal risks, and EHS aspects of sustainability and supply chain management.

CLE

If you would like CLE credit, please send the two CLE code words that were announced during the Roundtable to Lisa Reeher, [email protected], along with a completed evaluation form.